EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of In Vitro and Ex Vivo Biofilm Models for the Assessment of Antibacterial Fibrous Electrospun Wound Dressings

Kairi Lorenz, Liis Preem, Kadi Sagor, Marta Putrinš, Tanel Tenson, Karin Kogermann iD

Molecular Pharmaceutics · 06.02.2023 · 20 (2) · 1230-1246

DOI: 10.1021/acs.molpharmaceut.2c00902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 20.01.2023. Verfasst von Kairi Lorenz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy, University of Tartu, Nooruse 1, 50411 Tartu, Estonia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Wound Infection. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Regional Development Fund, Eesti Teadusagentuur.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing evidence suggests that the chronicity of wounds is associated with the presence of bacterial biofilms. Therefore, novel wound care products are being developed, which can inhibit biofilm formation and/or treat already formed biofilms. A lack of standardized assays for the analysis of such novel antibacterial drug delivery systems enhances the need for appropriate tools and models for their characterization. Herein, we demonstrate that optimized and biorelevant in vitro and ex vivo wound infection and biofilm models offer a convenient approach for the testing of novel antibacterial wound dressings for their antibacterial and antibiofilm properties, allowing one to obtain qualitative and quantitative results. The in vitro model was developed using an electrospun (ES) thermally crosslinked gelatin-glucose (GEL-Glu) matrix and an ex vivo wound infection model using pig ear skin. Wound pathogens were used for colonization and biofilm development on the GEL-Glu matrix or pig skin with superficial burn wounds. The in vitro model allowed us to obtain more reproducible results compared with the ex vivo model, whereas the ex vivo model had the advantage that several pathogens preferred to form a biofilm on pig skin compared with the GEL-Glu matrix. The in vitro model functioned poorly for Staphylococcus epidermidis biofilm formation, but it worked well for Escherichia coli and Staphylococcus aureus, which were able to use the GEL-Glu matrix as a nutrient source and not only as a surface for biofilm growth. On the other hand, all tested pathogens were equally able to produce a biofilm on the surface of pig skin. The developed biofilm models enabled us to compare different ES dressings [pristine and chloramphenicol-loaded polycaprolactone (PCL) and PCL-poly(ethylene oxide) (PEO) (PCL/PEO) dressings] and understand their biofilm inhibition and treatment properties on various pathogens. Furthermore, we show that biofilms were formed on the wound surface as well as on a wound dressing, indicating that the demonstrated methods mimic well the in vivo situation. Colony forming unit (CFU) counting and live biofilm matrix as well as bacterial DNA staining together with microscopic imaging were performed for biofilm quantification and visualization, respectively. The results showed that both wound biofilm models (in vitro and ex vivo) enabled the evaluation of the desired antibiofilm properties, thus facilitating the design and development of more effective wound care products and screening of various formulations and active substances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsWound InfectionSwineAnimalsChloramphenicolBiofilmsBandages

Stichwörter der Autor:innen

antibacterialantibiofilmelectrospinningex vivo biofilm modelin vitro biofilm modelskin wound infectionwound dressings

Substanzen

Anti-Bacterial AgentsChloramphenicol

Autor:innen und Institutionen

  • Institute of Pharmacy, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.
  • Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.

ORCID-Profile: Karin Kogermann

Förderung

  • European Regional Development Fund
  • Eesti Teadusagentuur

Zitieren

APA

Lorenz, K., Preem, L., Sagor, K., Putrinš, M., Tenson, T., & Kogermann, K. (2023). Development of In Vitro and Ex Vivo Biofilm Models for the Assessment of Antibacterial Fibrous Electrospun Wound Dressings. Molecular Pharmaceutics, 20(2), 1230-1246. https://doi.org/10.1021/acs.molpharmaceut.2c00902

Vancouver

Lorenz K, Preem L, Sagor K, Putrinš M, Tenson T, Kogermann K. Development of In Vitro and Ex Vivo Biofilm Models for the Assessment of Antibacterial Fibrous Electrospun Wound Dressings. Molecular Pharmaceutics. 2023;20(2):1230-1246. doi:10.1021/acs.molpharmaceut.2c00902

BibTeX
@article{Lorenz2023,
  author = {Lorenz, Kairi and Preem, Liis and Sagor, Kadi and Putrinš, Marta and Tenson, Tanel and Kogermann, Karin},
  title = {Development of In Vitro and Ex Vivo Biofilm Models for the Assessment of Antibacterial Fibrous Electrospun Wound Dressings},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  volume = {20},
  number = {2},
  pages = {1230--1246},
  doi = {10.1021/acs.molpharmaceut.2c00902}
}
Kostenlos starten →